These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23064919)

  • 21. Oral contraceptives and thromboembolism.
    Med Lett Drugs Ther; 1972 Aug; 14(17):61-2. PubMed ID: 4567564
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk of blood clots higher for oral contraceptives with certain progestins.
    Voelker R
    JAMA; 2011 Nov; 306(20):2206. PubMed ID: 22110099
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal replacement therapy--cardiovascular disease.
    Silfverstolpe G; Crona N
    Acta Obstet Gynecol Scand Suppl; 1986; 134():93-5. PubMed ID: 3028030
    [No Abstract]   [Full Text] [Related]  

  • 25. Fertility control with drugs.
    Tyler ET
    Postgrad Med; 1970 Jan; 47(1):82-6. PubMed ID: 5415143
    [No Abstract]   [Full Text] [Related]  

  • 26. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
    Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives.
    Raps M; Curvers J; Helmerhorst FM; Ballieux BE; Rosing J; Thomassen S; Rosendaal FR; van Vliet HA
    Thromb Res; 2014 Apr; 133(4):640-4. PubMed ID: 24438944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic stroke and myocardial infarction with hormonal contraception.
    Lidegaard Ø; Løkkegaard E; Jensen A; Skovlund CW; Keiding N
    N Engl J Med; 2012 Jun; 366(24):2257-66. PubMed ID: 22693997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiovascular risks of combined oral contraceptives - beyond the French controversy].
    Gronier H; Robin G
    Gynecol Obstet Fertil; 2014 Mar; 42(3):174-81. PubMed ID: 24582295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study.
    Le Moigne E; Tromeur C; Delluc A; Gouillou M; Alavi Z; Lacut K; Mottier D; Le Gal G
    Haematologica; 2016 Jan; 101(1):e12-4. PubMed ID: 26452982
    [No Abstract]   [Full Text] [Related]  

  • 32. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contraception at 40].
    André G
    Gynecol Obstet Fertil; 2002; 30(7-8):616-24. PubMed ID: 12199046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progestins for contraception: modern delivery systems and novel formulations.
    Royer PA; Jones KP
    Clin Obstet Gynecol; 2014 Dec; 57(4):644-58. PubMed ID: 25314087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3 further cases of icterus after taking estroprogestational agents and troleandomycin].
    Descotes J; Evreux JC; Foyatier N; Gaumer R; Girard D; Savoye B
    Nouv Presse Med; 1979 Mar; 8(14):1182-3. PubMed ID: 313558
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral contraception with estrogen and progestin combinations.
    Board JA
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):1-5. PubMed ID: 4992561
    [No Abstract]   [Full Text] [Related]  

  • 37. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral estro-progestational agents and the uterine cervix].
    de Brux J
    Pathol Eur; 1972; 7(3):283-7. PubMed ID: 4657185
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
    Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Review of the current status of research in steroid contraception].
    Vojta M
    Cesk Gynekol; 1970 Sep; 35(7):431-3. PubMed ID: 4924730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.